Intelligence · Clinical Development
Pipeline search results
Programs matching “dexamethasone” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 46 pipeline programs matching "dexamethasone" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
700 µg Dexamethasone
Allergan Pharmaceuticals International Limited
Macular Edema
1 trial -
DEXAMETHASONE for Onco-hematology
Pari Pharma GmbH
Onco-hematology
1 trial -
Dexamethasone
Quince Therapeutics
Crohn's Disease
1 trial -
Dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Distress Syndrome (ARDS)
1 trial -
Dexamethasone
United Therapeutics Europe Ltd
Shoulder Pain
1 trial -
Dexamethasone
Amgen
Relapsed Multiple Myeloma
1 trial -
Dexamethasone sodium phosphate
Quince Therapeutics
Ataxia Telangiectasia
2 trials -
Dexamethasone sodium phosphate for encapsulation into autoerythrocytes
Quince Therapeutics
Ataxia Telangiectasia (A-T)
1 trial -
ETOPOSIDE , DEXAMETHASONE
Pari Pharma GmbH
Hemophagocytic lymphohistiocytosis (HLH)
1 trial -
FST-201 (dexamethasone 0.1%) Otic Suspension
Takeda
Acute Otitis Externa
1 trial -
FST-201 (dexamethasone 0.1%) Otic Suspension
Takeda
Acute Fungal Otitis Externa
1 trial -
FST201 (dexamethasone 0.1% with povidone-iodine 1%)
Takeda
Acute Otitis Externa
1 trial -
HM16/047
Takeda
Multiple Myeloma
1 trial -
MyelomaXIV
Takeda
Multiple Myeloma
1 trial -
NaCl 0.9%, DEXAMETHASONE
Pari Pharma GmbH
Cervicobrachial Neuralgia
1 trial -
Oral dexamethasone
Hospital Authority, Hong Kong
Bronchiolitis
1 trial -
Placebo, Velcade and dexamethasone
Centocor B.V.
Multiple Myeloma
1 trial -
dexamethasone
Ultragenyx UK Limited
Bronchopulmonary Dysplasia
1 trial -
recombinant human thrombopoietin (rhTPO); dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Purpura
1 trial -
DEXAMETHASONE for Patients with relapsed/refracto…
Pari Pharma GmbH
Patients with relapsed/refractory symptomatic multiple myeloma (MM)
1 trial -
Dexamethasone
Quince Therapeutics
Nervous System Disorder
1 trial -
Dexamethasone
Kura Oncology
Lymphoblastic Leukemia
1 trial -
Dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ITP
1 trial -
Dexamethasone
United Therapeutics Europe Ltd
Voice Change
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.